金吾财讯 | 药明生物(02269)震荡走强,截至发稿,涨4%,报29.9港元,成交额13.65亿港元。消息面上,药明生物公布,根据对集团截至2025年6月30日止六个月的未经审核综合管理账目(基于国际财务报告准则(IFRS)编制)的初步评估,集团预期与去年同期比较,截至2025年6月30日止六个月所录得的公司收益将增长约16%;毛利率将同比提升约3.6%;公司截至2025年6月30日止六个月的...
Source Link金吾财讯 | 药明生物(02269)震荡走强,截至发稿,涨4%,报29.9港元,成交额13.65亿港元。消息面上,药明生物公布,根据对集团截至2025年6月30日止六个月的未经审核综合管理账目(基于国际财务报告准则(IFRS)编制)的初步评估,集团预期与去年同期比较,截至2025年6月30日止六个月所录得的公司收益将增长约16%;毛利率将同比提升约3.6%;公司截至2025年6月30日止六个月的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.